Physician profile
Robyn James
NPI 1861561730
$927.96
in general payments reported to CMS, 2019-2025
16 companies · $266 in 2025
The $266 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.53 · 2021: $301 · 2022: $211 · 2023: $120 · 2024: $15.21 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $230.36 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $100.81 | 2023 | |
| Incyte Corporation | $91.63 | 2021-2022 | |
| Medimetriks Pharmaceuticals, INC. | $71.60 | 2025 | |
| Strata Skin Sciences, INC. | $67.17 | 2025 | Xtrac |
| Organon LLC | $58.97 | 2025 | |
| Lilly USA, LLC | $48.01 | 2021-2022 | |
| Leo Pharma INC. | $46.98 | 2021-2022 | |
| Ucb, INC. | $43.97 | 2021-2023 | Cimzia |
| Janssen Biotech, INC. | $38.71 | 2021-2025 | Tremfya |
| Amgen INC. | $36.18 | 2021 | |
| Novartis Pharmaceuticals Corporation | $23.58 | 2021 | |
| Allergan, INC. | $20.07 | 2021 | |
| Sun Pharmaceutical Industries INC. | $19.18 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.53 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $15.21 | 2024 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robyn James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.